Literature DB >> 25083888

Polycystic ovary syndrome--phenotypes and diagnosis.

Charikleia Christakou1, Evanthia Diamanti-Kandarakis.   

Abstract

Polycystic ovary syndrome (PCOS) is a heterogeneous spectrum of symptoms lasting throughout the lifecycle. The syndrome combines reproductive as well as metabolic aberrations associated with increased cardiovascular risk. The presence of three different definitions for the diagnosis of PCOS reflects the phenotypic diversity of the syndrome. The clinical manifestations and the sequelae of PCOS vary throughout the lifecycle, partly depending on environmental factors which may affect the integral components of the syndrome, namely ovarian steroidogenesis, ovulation and insulin resistance. As the patient grows older, particularly in the postmenopausal period, the cardiovascular risk profile may translate into increased rates of cardiovascular morbidity.

Entities:  

Keywords:  Polycystic ovary syndrome; lifecycle; phenotypes

Mesh:

Substances:

Year:  2014        PMID: 25083888     DOI: 10.3109/00365513.2014.936675

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  7 in total

1.  Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients.

Authors:  Xin Huang; Cuifang Hao; Hongchu Bao; Meimei Wang; Huangguan Dai
Journal:  J Assist Reprod Genet       Date:  2015-12-09       Impact factor: 3.412

Review 2.  Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.

Authors:  Renae C Fernandez; Vivienne M Moore; Emer M Van Ryswyk; Tamara J Varcoe; Raymond J Rodgers; Wendy A March; Lisa J Moran; Jodie C Avery; R Doug McEvoy; Michael J Davies
Journal:  Nat Sci Sleep       Date:  2018-02-01

3.  Identification of mRNAs related to endometrium function regulated by lncRNA CD36-005 in rat endometrial stromal cells.

Authors:  Xueying Zhang; Ying Xu; Lulu Fu; Dandan Li; Xiaowei Dai; Lianlian Liu; Jingshun Zhang; Lianwen Zheng; Manhua Cui
Journal:  Reprod Biol Endocrinol       Date:  2018-10-15       Impact factor: 5.211

4.  Identification of Three Potential circRNA Biomarkers of Polycystic Ovary Syndrome by Bioinformatics Analysis and Validation.

Authors:  Pengyu Huang; Shengrong Du; Yunhong Lin; Zhiqing Huang; Haiyan Li; Gangxin Chen; Suzhu Chen; Qingfen Chen; Lincui Da; Hang Shi; Wei Wei; Lei Yang; Yan Sun; Beihong Zheng
Journal:  Int J Gen Med       Date:  2021-09-22

5.  Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS.

Authors:  Xin Huang; Jiaping Pan; Bi Wu; Xiaoming Teng
Journal:  Reprod Biol Endocrinol       Date:  2018-08-03       Impact factor: 5.211

Review 6.  Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health.

Authors:  Vidhu Gill; Vijay Kumar; Kritanjali Singh; Ashok Kumar; Jong-Joo Kim
Journal:  Biomolecules       Date:  2019-12-17

7.  Divergences in Clinical, Anthropometric, Metabolic, and Hormonal Parameters among Different Phenotypes of Polycystic Ovary Syndrome Presenting at Endocrinology Outpatient Departments: A Multicenter Study from Bangladesh.

Authors:  A B M Kamrul-Hasan; Fatema Tuz Zahura Aalpona; Marufa Mustari; Farhana Akter; Mohammad Motiur Rahman; Shahjada Selim
Journal:  J Hum Reprod Sci       Date:  2020-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.